Attempts at altering ureteral activity in the unanesthetized, conditioned dog with commonly employed drugs.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000420:Albuterol / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D003214:Conditioning, Classical; D003620:Dantrolene / Q000494:pharmacology; D003975:Diazepam / Q000494:pharmacology; D004285:Dogs; D005260:Female; D006221:Halothane / Q000494:pharmacology; D008688:Methacholine Compounds / Q000494:pharmacology; D008722:Methods; D009132:Muscles / Q000187:drug effects; D009411:Nerve Endings / Q000187:drug effects; D009609:Nitrous Oxide / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010425:Pentolinium Tartrate / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011413:Propantheline / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013726:Terbutaline / Q000494:pharmacology; D013748:Tetracaine / Q000494:pharmacology; D014513:Ureter / Q000187:drug effects* / Q000294:innervation
D000318:Adrenergic beta-Agonists; D000700:Analgesics; D008688:Methacholine Compounds; D013748:Tetracaine; D010643:Phenoxybenzamine; D011413:Propantheline; D001285:Atropine; D010425:Pentolinium Tartrate; D011433:Propranolol; D003620:Dantrolene; D010424:Pentobarbital; D009609:Nitrous Oxide; D013726:Terbutaline; D003975:Diazepam; D000420:Albuterol; D006221:Halothane